Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 901–1,000 of 1,002
Loiseau, D., Morvan, D., Chevrollier, A., Demidem, A., Douay, O., Reynier, P., & Stepien, G. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20539 · Cited by 28
Oxygen as a chemoattractant: confirming cellular hypoxia in paper-based invasion assays
Truong, A. S., & Lockett, M. R. (2016) · The Analyst · doi:10.1039/c6an00630b · Cited by 31
Huizing, F. J., Hoeben, B. A. W., Franssen, G. M., Boerman, O. C., Heskamp, S., & Bussink, J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00950 · Cited by 30
Huang, G., Si, Z., Yang, S., Li, C., & Xing, D. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm33990k · Cited by 27
L-Glucose: Another Path to Cancer Cells
Ono, K., Takigawa, S., & Yamada, K. (2020) · Cancers · doi:10.3390/cancers12040850 · Cited by 28
Zhang, H., Lü, F., Pan, W., Ge, Y., Cui, B., Gong, S., Li, N., & Tang, B. (2021) · Biomaterials Science · doi:10.1039/d1bm00240f · Cited by 27
Aboulthana, W. M., Shousha, W. G., Essawy, E. A.-R., Saleh, M., & Salama, A. H. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.10.3267 · Cited by 28
Jo, H. J., Im, G., Robby, A. I., In, I., Bhang, S. H., Shit, A., & Park, S. Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140729 · Cited by 27
Li, X., Li, Y., Liu, B., Chen, L., Lyu, F., Zhang, P., He, Q., Cheng, L., Liu, C., Song, Y., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201247r · Cited by 27
c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer
Wang, L., Xue, M., & Chung, D. C. (2016) · Oncotarget · doi:10.18632/oncotarget.12911 · Cited by 30
Jesus, T. F., Moreno, J. M., Repolho, T., Athanasiadis, A., Rosa, R., de Almeida‐Val, V. M. F., & Coelho, M. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181325 · Cited by 27
Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 33
GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways
Park, S. H., Kim, B.-R., Lee, J. H., Park, S. T., Lee, S., Dong, S. M., & Rho, S. B. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.017 · Cited by 28
Metabolomics and cellular altered pathways in cancer biology: A review
Bhardwaj, J. K., Siwach, A., & Sachdeva, S. N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23807 · Cited by 28
Beielstein, A. C., & Pallasch, C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174158 · Cited by 26
Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas
Miro, C., Nappi, A., Cicatiello, A. G., Cicco, E. D., Sagliocchi, S., Murolo, M., Belli, V., Troiani, T., Albanese, S., Amiranda, S., et al. (2021) · Cancers · doi:10.3390/cancers13112743 · Cited by 27
Tian, F., Li, F., Ren, L., Wang, Q., Jiang, C., Zhang, Y., Li, M., Song, X., & Zhang, S. (2022) · ACS Sensors · doi:10.1021/acssensors.2c02129 · Cited by 26
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
Pang, Y., Lu, T., Xu-Monette, Z. Y., & Young, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065493 · Cited by 31
Casas-Benito, A., Martínez-Herrero, S., & Martínez, A. (2023) · Cancers · doi:10.3390/cancers15102862 · Cited by 31
Gaber, T., Tran, C. L., Schellmann, S., Hahne, M., Strehl, C., Hoff, P., Radbruch, A., Burmester, G. R., & Buttgereit, F. (2013) · European Journal of Immunology · doi:10.1002/eji.201242754 · Cited by 31
Zeng, Q., Zhang, P., Wu, Z., Xue, P., Lü, D., Ye, Z., Zhang, X., Huang, Z., Feng, J., Song, L., et al. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.03.033 · Cited by 26
Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells
Hsieh, I., Yang, R., & Fu, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109550 · Cited by 27
Oxygen sensor boosts growth factor signaling
Hung, M., Mills, G. B., & Yu, D. (2009) · Nature Medicine · doi:10.1038/nm0309-246 · Cited by 28
Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers
Vasconcelos, M. G., VASCONCELOS, R. G., de Oliveira, D. H. I. P., Santos, E. D. M., Pinto, L. P., da Silveira, É. J. D., & Queiroz, L. M. G. (2015) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2015.03.013 · Cited by 26
An Overview of Unfolded Protein Response Signaling and Its Role in Cancer
Jain, B. P. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2309 · Cited by 30
γ-secretase inhibition lowers plasma triglyceride-rich lipoproteins by stabilizing the LDL receptor
Kim, K., Goldberg, I. J., Graham, M. J., Sundaram, M., Bertaggia, E., Lee, S. X., Qiang, L., Haeusler, R. A., Metzger, D., Chambon, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.010 · Cited by 26
A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
Liu, W., Zhang, B., Hu, Q., Qin, Y., Xu, W., Shi, S., Liang, C., Meng, Q., Xiang, J., Liang, D., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3938 · Cited by 26
Early pregnancy on the diaphragm with endometriosis.
Norenberg, D. D., Gundersen, J. H., Janis, J. F., & Gundersen, A. L. (1977) · PubMed · Cited by 30
Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells
Plecitá‐Hlavatá, L., Ježek, J., & Ježek, P. (2015) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-015-9628-6 · Cited by 26
Wang, S., Zhang, C., Liu, X., Chen, Z., Peng, S., Zhong, Z., & Zhang, X. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900012 · Cited by 25
Tang, Y., Shi, H., Cheng, D., Zhang, J., Lin, Y., Xu, Y. F., Qian, X. H., & Zhu, W. P. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.03.049 · Cited by 25
Wan, S., Liu, M., Qian, C., Cheng, H. L., & Zhang, X. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000019 · Cited by 28
Tumor-intrinsic FABP5 is a novel driver for colon cancer cell growth via the HIF-1 signaling pathway
Seo, J., Yun, J.-E., Fukuda, J., & Chun, Y. (2021) · Cancer Genetics · doi:10.1016/j.cancergen.2021.11.001 · Cited by 27
Intersections between mitochondrial sirtuin signaling and tumor cell metabolism
Herrera, K. N. G., Lee, J. J., & Haigis, M. C. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1031879 · Cited by 28
Baumann, R. P., Ishiguro, K., Penketh, P. G., Shyam, K., Zhu, R., & Sartorelli, A. C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.019 · Cited by 25
Luo, Z., Loja, M. N., Farwell, D. G., Luu, Q. C., Donald, P. J., Amott, D., Truong, A. Q., Gandour‐Edwards, R. F., & Nitin, N. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0097 · Cited by 25
Shen, M., Cao, J., & Shi, H. (2018) · International Journal of Endocrinology · doi:10.1155/2018/5789127 · Cited by 27
SCF β‐Tr CP ubiquitinates CHK 1 in an AMPK ‐dependent manner in response to glucose deprivation
Ma, Y., Cui, D., Xiong, X., Inuzuka, H., Wei, W., Sun, Y. N., North, B. J., & Zhao, Y. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12403 · Cited by 27
The Role of miR-210 in the Biological System: A Current Overview
Xu, H., Al-Ward, H., Shaher, F., Liu, C., & Liu, N. (2019) · Human Heredity · doi:10.1159/000509280 · Cited by 28
Lin, S.-P., Kuo, Y., Weng, Y., Lai, I., Huang, T. H. ‐., Lin, S., Niu, D., & Chen, C. (2012) · The Prostate · doi:10.1002/pros.22530 · Cited by 25
Padmanabha, D., Padilla, P. A., You, Y., & Baker, K. D. (2014) · Genetics · doi:10.1534/genetics.114.173989 · Cited by 25
TRAIL-Based Therapy in Pediatric Bone Tumors: How to Overcome Resistance
Guiho, R., Biteau, K., Heymann, D., & Rédiní, F. (2015) · Future Oncology · doi:10.2217/fon.14.293 · Cited by 24
Ahmed, M. A. M., & Nagelkerke, A. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100012 · Cited by 25
Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment
Seo, J., Yun, J.-E., Kim, S. J., & Chun, Y. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02683-x · Cited by 28
Luo, H., Song, Y., Zhang, J., Liu, Y., Chen, F., Wang, Z. P., & Zhu, X. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00987-6 · Cited by 26
Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism
Gu, Z., & Yu, C. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01740-y · Cited by 24
Sha, W., Olesch, C., Hanaka, H., Rådmark, O., Weigert, A., & Brüne, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28181 · Cited by 26
Regulation of aerobic glycolysis by long non-coding RNAs in cancer
Kong, X.-Z., Hu, S., Sun, Z., Zuo, L., Kang, J., Zhu, Z.-F., Tian, X., & Zhang, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.007 · Cited by 25
Matsuo, T., & Sadzuka, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.022 · Cited by 24
Si, H. Y., Cho, M. K., Kang, J. S., Noh, C., Shin, S. J., Lim, C. S., & Kim, H. M. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01114 · Cited by 24
Alhawarat, F., Hammad, H. M., Hijjawi, M. S., Sharab, A., Abuarqoub, D. A., Shhab, M. A. A., & Zihlif, M. A. (2019) · PeerJ · doi:10.7717/peerj.5990 · Cited by 26
More Than Just a Bandage: Closing the Gap Between Injury and Appendage Regeneration
Kakebeen, A. D., & Wills, A. E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00081 · Cited by 24
Park, J. E., Tse, S. W., Guo, X., Assisi, C., Serra, A., Ramon, G. P. X., Low, J. K., Kon, O. L., Tay, C. Y., Tam, J. P., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.26669 · Cited by 24
Fuse, S., Suzuki, K., Kuchimaru, T., Kadonosono, T., Ueda, H., Sato, S., Kizaka‐Kondoh, S., & Nakamura, H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115207 · Cited by 24
García-Vence, M., Chantada‐Vázquez, M. D. P., Cameselle‐Teijeiro, J., Bravo, S. B., & Núñez, C. (2020) · Nanomaterials · doi:10.3390/nano10122370 · Cited by 24
Diabetic vascular disease and the potential role of macrophage glucose metabolism
Nishizawa, T., & Bornfeldt, K. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.585346 · Cited by 30
Polidarová, L., Sládek, M., Nováková, M., Parkanová, D., & Sumová, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075690 · Cited by 26
Wang, P., Zhang, X., Liu, F., & Wang, W. (2025) · Research · doi:10.34133/research.0651 · Cited by 30
Wang, H., Jia, R., Zhao, T., Li, X., Lang, M., Lan, C., Wang, H., Li, Z., Zhou, B., Wu, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.036 · Cited by 23
RetractedSun, L., Zhang, L.-Y., Shan, F., Shen, M., & Ruan, S. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60015-8 · Cited by 37
Horie, M., Takagane, K., Itoh, G., Kuriyama, S., Yanagihara, K., Yashiro, M., Umakoshi, M., Goto, A., Arita, J., & Tanaka, M. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13524 · Cited by 25
Optical functional nanomaterials for cancer photoimmunotherapy
Liu, L., Pan, Y., Ye, L., Liang, C., Mou, X., Dong, X., & Cai, Y. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216006 · Cited by 23
Bartkowiak, K., Riethdorf, S., & Pantel, K. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0067-6 · Cited by 24
Chen, C.-H., Huang, P.-H., Chu, P., Chen, M.-C., Chou, C.-C., Wang, D.-S., Kulp, S. K., Teng, C., Wang, Q., & Chen, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203240 · Cited by 27
Hypoxia‐inducible factors – regulation, role and comparative aspects in tumourigenesis
Hansen, A. E., Kristensen, A. T., Law, I. G., Jørgensen, J. T., & Engelholm, S. A. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00233.x · Cited by 27
Hara, T., Mimura, K., Seiki, M., & Sakamoto, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.085 · Cited by 26
c-MYC responds to glucose deprivation in a cell-type-dependent manner
Wu, S., Yin, X., Fang, X., Zheng, J., Li, L., Liu, X., & Chu, L. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.57 · Cited by 24
Ye, M., Fang, Z., Gu, H., Song, R. Y., Ye, J., Li, H., Wu, Z., Zhou, S., Li, P., Cai, X., et al. (2017) · Tumor Biology · doi:10.1177/1010428317705034 · Cited by 23
ERG the modulates Warburg effect and tumor progression in cervical cancer
Zhang, Z., Chen, F., Li, S., Guo, H.-Y., Xi, H., Deng, J., Han, Q., & Zhang, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.079 · Cited by 27
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2
Shen, M., Xu, M., Zhong, F., Crist, M., Prior, A. B., Yang, K., Allaire, D. M., Choueiry, F., Zhu, J., & Shi, H. (2021) · Cells · doi:10.3390/cells10020455 · Cited by 25
Zheng, X., Tang, H., Xie, C., Zhang, J., Wu, W., & Jiang, X. (2015) · Angewandte Chemie · doi:10.1002/ange.201503067 · Cited by 23
Wang, J., Xu, W., Qian, J., Wang, Y., Hou, G., Suo, A., & Ma, Y. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.08.024 · Cited by 22
Lee, B., Park, O. K., Pan, L., Kim, K., Kang, T., Kim, H., Lee, N., Choi, S. H., & Hyeon, T. (2023) · Advanced Materials · doi:10.1002/adma.202305512 · Cited by 23
Li, J., Li, B., Liu, F., Deng, M., Zhang, Z., Ran, Y., & Wang, B. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.10.024 · Cited by 24
Oleksyszyn, J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.04.001 · Cited by 22
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
Cimini, A., d’Angelo, M., Benedetti, E., D’Angelo, B., Laurenti, G., Antonosante, A., Cristiano, L., Mambro, A. D., Barbarino, M., Castelli, V., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25421 · Cited by 23
Zhu, H., Wang, H., Huang, Q., Liu, Q., Guo, Y., Lu, J., Li, X., Xue, C., & Han, Q. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00187 · Cited by 23
O’Neill, H., Malik, V. K., Johnston, C. J., Reynolds, J. V., & O'Sullivan, J. N. (2019) · Pharmaceuticals · doi:10.3390/ph12010016 · Cited by 24
Lamberti, M. J., Rettel, M., Krijgsveld, J., Rivarola, V. A., & Vittar, N. B. R. (2019) · Cellular Oncology · doi:10.1007/s13402-018-00418-8 · Cited by 23
Emodin: Its role in prostate cancer‑associated inflammation (Review)
Tu, Y., Wu, Z., Tan, B., Yang, A., & Fang, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7264 · Cited by 28
Fu, Y., Cen, D., Zhang, T., Jiang, S., Wang, Y., Cai, X., Li, X., & Han, G. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126204 · Cited by 22
MYD88 signals induce tumour-initiating cell generation through the NF-κB-HIF-1α activation cascade
Tanimura, A., Nakazato, A., & Tanaka, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-83603-4 · Cited by 23
The Role of MicroRNAs in Lung Cancer Metabolism
Azizi, M. I. H. N., Othman, I., & Naidu, R. (2021) · Cancers · doi:10.3390/cancers13071716 · Cited by 25
Qin, Y., Zheng, Y., Huang, C., Li, Y., Gu, M., & Wu, Q. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.683725 · Cited by 22
Peng, K., Zhuo, M., Li, M., Chen, Q., Mo, P., & Yu, C. (2021) · Oncogene · doi:10.1038/s41388-021-01678-9 · Cited by 22
Kang, G., Hu, M., Ren, H., Wang, J., Cheng, X. M., Li, R., Yuan, B., Balan, Y., Bai, Z., & Huang, H. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0568 · Cited by 22
Yang, Y., Liang, X., Saiding, Q., Lin, J., Li, J., Wang, W., Huang, P., Huang, L., Zeng, W., Huang, J., et al. (2024) · Materials Today · doi:10.1016/j.mattod.2024.07.012 · Cited by 21
Han, Y., Chen, Q., Zhang, L., & Dissanayaka, W. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.655073 · Cited by 23
Lu, F., Fang, D., Li, S., Zhong, Z., Jiang, X., Qi, Q., Liu, Y., Zhang, W., Xu, X., Liu, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71809 · Cited by 21
Importance of lactate dehydrogenase (LDH) and monocarboxylate transporters (MCTs) in cancer cells
Hatami, H., Sajedi, A., Mir, S. M., & Memar, M. Y. (2022) · Health Science Reports · doi:10.1002/hsr2.996 · Cited by 21
Guo, N., Yang, A., Farooq, F. B., Kalaria, S., Moss, E., DeVorkin, L., Lesperance, M., Bénard, F., Wilson, D. C., Tinker, A. V., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30655-3 · Cited by 24
Georgopoulou, T., Petrakis, I., Dermitzaki, K. E., Pleros, C., Drosataki, E., Aletras, G., Foukarakis, E. G., Lioudaki, E., Androulakis, E. S., & Stylianou, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124121 · Cited by 21
T4 Phage Display Technology for Enhanced Photodynamic Therapy of Breast Cancer
Hou, X. L., Xie, X., Tan, L., Zhang, F., Fan, J., Chen, W., Hu, Y., Zhao, Y., Liu, B., & Xu, Q. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.3c00527 · Cited by 21
Phosphoglycerate Kinase 1: An Effective Therapeutic Target in Cancer
Qiu, A., Wen, X., Zou, Q., Yin, L., Zhu, S., Yao, S., He, Y., Liu, Q., Luo, D., & Guo, Z. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2903092 · Cited by 23
Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia
Velasco-Hernández, T., Tornero, D., & Cammenga, J. (2015) · Leukemia · doi:10.1038/leu.2015.156 · Cited by 22
The metabolic switch and its regulation in cancer cells
Zhou, S., Huang, C., & Wei, Y. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4041-1 · Cited by 25
Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 23
Wu, H., Exner, A. A., Shi, H., Bear, J. J., & Haaga, J. R. (2009) · Academic Radiology · doi:10.1016/j.acra.2009.09.009 · Cited by 21
Sasaki, T., Kanaseki, T., Shionoya, Y., Tokita, S., Miyamoto, S., Saka, E., Kochin, V., Takasawa, A., Hirohashi, Y., Tamura, Y., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201545835 · Cited by 23
Strous, M. T. A., Faes, T. K. E., Gubbels, A. L. H. M., van der Linden, R. L. A., Mesker, W. E., Bosscha, K., Bronkhorst, C. M., Janssen-Heijnen, M. L. G., Vogelaar, F. J., & de Bruïne, A. P. (2022) · Clinical and Translational Oncology · doi:10.1007/s12094-021-02746-y · Cited by 20
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.